BioMarin Pharmaceuticals BMRN Total costs & expenses

Total costs & expenses at other companies

Sarepta Therapeutics, Inc.SRPT

$387.96M-21.7%

Zevra Therapeutics, Inc.ZVRA

$21.05M-13.1%

Agios PharmaceuticalsAGIO

$155.3M+11.3%

RegenxbioRGNX

$78.76M-6.9%

BridgeBio PharmaBBIO

$300.47M+36.0%

Crinetics PharmaceuticalsCRNX

$151.11M+35.2%

FAQ

What is BioMarin Pharmaceuticals's total costs & expenses?

BioMarin Pharmaceuticals (BMRN) reported total costs & expenses of $878.79M in Q2 2026.

How has BioMarin Pharmaceuticals's total costs & expenses changed year-over-year?

BioMarin Pharmaceuticals's total costs & expenses increased by 60.2% year-over-year, from $548.52M to $878.79M.

What is the long-term trend for BioMarin Pharmaceuticals's total costs & expenses?

Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's total costs & expenses has grown at a 9.9% compound annual growth rate (CAGR), from $1.93B to $2.81B.

What does total costs & expenses mean?

Total costs and expenses aggregate all operating and non-operating costs incurred to generate revenue during the period. It provides a comprehensive view of the company's total expenditure structure.